Storia della carriera di Robert Freisen
Precedenti posizioni note di Robert Freisen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ABLYNX | Direttore Tecnico/Scientifico/R&S | 01/03/2018 | 01/01/2019 |
| PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 01/01/2016 | 01/01/2018 |
| Janssen Biotherapeutics | Corporate Officer/Principal | 01/01/2008 | 01/01/2014 |
| MORPHOSYS AG | Corporate Officer/Principal | - | - |
Formazione di Robert Freisen
| The University of Texas at Austin | Doctorate Degree |
| University of Utrecht | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Belgio | 3 |
| Paesi Bassi | 3 |
| Germania | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MORPHOSYS AG | Health Technology |
| PROQR THERAPEUTICS N.V. | Health Technology |
| Aziende private | 2 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
| Janssen Biotherapeutics |
- Borsa valori
- Insiders
- Robert Freisen
- Esperienza
